Lung Cancer Clinical Trial

Specimen Banking From Patients With Lung Cancer

Summary

The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translation research, which will enable the investigators to detect lung cancer earlier, develop better therapies and explore screening and prevention strategies.

View Full Description

Full Description

The aims of the study are as follows: 1) to continue to unravel the complex biology of lung cancer 2) to identify early detection and prognostic markers to guide therapeutic decision 3) to define markers of response and/or resistance to drug therapy, and 4) to identify new therapeutic and prevention targets.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Subjects who are undergoing further testing for the diagnosis or treatment of lung cancer.
Oral and written informed consent

Exclusion Criteria:

1. Any individual who does not give oral and written consent for participation

Study is for people with:

Lung Cancer

Estimated Enrollment:

1000

Study ID:

NCT01585675

Recruitment Status:

Recruiting

Sponsor:

University of Colorado, Denver

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Colorado Cancer Center
Aurora Colorado, 80045, United States More Info
Brandi Kubala
Contact
303-724-1657
[email protected]
Adriaan VanBokhoven, PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

1000

Study ID:

NCT01585675

Recruitment Status:

Recruiting

Sponsor:


University of Colorado, Denver

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.